Compare HKD & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HKD | CYRX |
|---|---|---|
| Founded | 2003 | 1999 |
| Country | France | United States |
| Employees | N/A | 1100 |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 446.3M | 421.6M |
| IPO Year | 2021 | 2008 |
| Metric | HKD | CYRX |
|---|---|---|
| Price | $1.58 | $8.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.94 |
| AVG Volume (30 Days) | ★ 681.5K | 341.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $9.71 |
| Revenue Next Year | N/A | $9.56 |
| P/E Ratio | $14.10 | ★ $4.99 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.26 | $4.63 |
| 52 Week High | $5.47 | $11.45 |
| Indicator | HKD | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.04 | 37.26 |
| Support Level | $1.32 | $6.57 |
| Resistance Level | $1.68 | $8.45 |
| Average True Range (ATR) | 0.15 | 0.51 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 22.30 | 25.71 |
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment, hotel operations, hospitality and VIP services segment and media and entertainment services. The company generates maximum revenue by providing financial digital solutions through its insurance brokerage services and other digital solutions services. Geographically, the company generates maximum revenue from Hong Kong and Singapore.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.